New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 8, 2013
18:58 EDTSTAA, GILD, AA, SHLM, JCP, OCZ, STWDOn The Fly: After Hours Movers
UP AFTER EARNINGS: Staar Surgical (STAA), up 21% after the company announced preliminary Q1 revenue that beat current estimates... ALSO HIGHER: Gilead (GILD), up 2% after submitting an new drug application to the FDA for its hepatitis C treatment sofosbuvir... DOWN AFTER EARNINGS: Alcoa (AA), down 1.7%... A. Schulman (SHLM), down 5.8%... ALSO LOWER: J.C. Penney (JCP), down 6.8% after the company announced CEO Ron Johnson was stepping down and will be replaced by former CEO Myron "Mike" Ullman... OCZ Technology (OCZ), down 12% after the company announced it would not meet an April 8 filing deadline with the SEC... Starwood Property (STWD), down 2.6% after announcing 26.5M common share offering.
News For STAA;GILD;AA;SHLM;JCP;OCZ;STWD From The Last 14 Days
Check below for free stories on STAA;GILD;AA;SHLM;JCP;OCZ;STWD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 8, 2014
09:35 EDTAAActive equity options trading on open
Subscribe for More Information
09:00 EDTSTWDStarwood Property 22M share Spot Secondary priced at $22.55
Subscribe for More Information
08:32 EDTSHLMA. Schulman board authorizes $55M stock buyback program
The new Program replaces the Company's previous share repurchase program, which was authorized on April 1, 2011, and expired March 31. Under the previous program, shares valued at $55.5m remained authorized for repurchase.
07:31 EDTAAFutures suggest lower open for broader market
Stock futures are pointing to a moderately lower open as the market will try to reverse its recent downward trend. Investors will receive little help throughout the day, as little economic data is slated to be released. The Nasdaq has led the market lower, as it has seen its biggest three day drop since November 2011. The unofficial kickoff of the earnings season will occur tonight, when Alcoa (AA) is scheduled to release its first quarter results.
April 7, 2014
16:52 EDTSHLMA. Schulman up over 6% to $38.61 following results, increased FY14 guidance
16:38 EDTSHLMA. Schulman raises FY14 adjusted EPS to $2.23-$2.28 from $2.08-$2.13
Consensus $2.16. Joseph M. Gingo, chairman, president and CEO, said, "Driven by the trend of our positive European results, the continuation of relatively stable raw material pricing and modest global economic growth, we have raised our expectations for 2014 adjusted net income to a range of $2.23-$2.28 per diluted share, which would represent an approximately 25% increase over the prior-year results using the high-end of this range."
16:36 EDTSHLMA. Schulman reports Q2 EPS ex-items 39c, consensus 33c
Reports Q2 revenue $588.51M, one estimate $575M. Bernard Rzepka, COO, stated, "I am very pleased that our European team has been able to capitalize on strengthening demand, especially in the automotive and electronics & electrical markets. In the Americas, I am encouraged that organic net sales in the region remained consistent with the prior year despite an 8.2% drop in organic volume and negative foreign currency headwinds in Latin America. Volume was, of course, impacted by the severe winter weather in the U.S., but also by the company's continuous strategy to reduce less-profitable commodity sales. In Asia Pacific, or APAC, the addition of our Perrite Group's Malaysian facility has led to significant growth and provides us with solid engineered plastics operations in Southeast Asia. Additionally, we are seeing organic growth across all product families in the region, as well as a stabilization of gross margins on a sequential basis. APAC is a key strategic market for us, and we are pleased with our progress in the region."
16:14 EDTSTWDStarwood Property files to sell 22M shares of common stock
Subscribe for More Information
15:11 EDTSHLMNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include A. Schulman (SHLM), consensus 33c; Team, Inc. (TISI), consensus 0c; Zep, Inc. (ZEP), consensus 8c.
12:38 EDTAAEarnings Preview: Alcoa shares near 52-week high ahead of Q1 report
Subscribe for More Information
10:00 EDTAAOn The Fly: Analyst Upgrade Summary
Agios Pharmaceuticals (AGIO) upgraded to Overweight from Neutral at JPMorgan... Alcoa (AA) upgraded to Hold from Sell at Deutsche Bank... Align Technology (ALGN) upgraded to Outperform from Market Perform at Barrington... Analog Devices (ADI) upgraded to Neutral from Sell at Goldman... B&G Foods (BGS) upgraded to Outperform from Sector Perform at RBC Capital... Citigroup (C) upgraded to Neutral from Underweight at HSBC... Intel (INTC) upgraded to Outperform from Sector Perform at Pacific Crest... JetBlue (JBLU) upgraded to Neutral from Sell at Goldman... Kindred Healthcare (KND) upgraded to Outperform from Sector Perform at RBC Capital... Lennox (LII) upgraded to Outperform from Market Perform at Wells Fargo... Newmont Mining (NEM) upgraded to Hold from Sell at Deutsche Bank... PBF Energy (PBF) upgraded to Buy from Neutral at Citigroup... Renasant (RNST) upgraded to Outperform from Market Perform at Raymond James... Select Medical (SEM) upgraded to Outperform from Sector Perform at RBC Capital... Ultra Petroleum (UPL) upgraded to Outperform from Market Perform at Raymond James... Under Armour (UA) upgraded to Buy from Neutral at Sterne Agee... Hercules Technology (HTGC) upgraded to Buy from Hold at Sandler ONeill... Standard Pacific (SPF) upgraded to Outperform from Market Perform at Raymond James... Yelp (YELP) upgraded to Outperform from Perform at Oppenheimer... Netflix (NFLX) upgraded to Outperform from Perform at Oppenheimer... Pandora (P) upgraded to Outperform from Neutral at Wedbush.
09:34 EDTGILDActive equity options trading on open
Subscribe for More Information
08:31 EDTGILDGilead announecs FDA priority review designation for Ledipasvir/Sofosbuvir
Gilead Sciences announced that the U.S. Food and Drug Administration has granted priority review to the company’s New Drug Application for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults. Gilead filed the NDA for LDV/SOF on February 10, and the FDA has set a target action date under the Prescription Drug User Fee Act of October 10. The FDA has also assigned LDV/SOF a Breakthrough Therapy designation.
07:59 EDTAAAlcoa April volatility elevated, shares near 32-month high into Q1
Alcoa April weekly call option implied volatility is at 65, April is at 44, May is 35, June and September is at 32; compared to its 26-week average of 32 according to Track Data, suggesting large near term price movement into its expected release of Q1 results after the market close on April 8.
06:28 EDTJCPStocks with implied volatility below IV index mean; SWY JCP
Subscribe for More Information
06:28 EDTAAAlcoa upgraded to Hold from Sell at Deutsche Bank
Deutsche Bank upgraded Alcoa to Hold citing its more positive view on aluminum premia due to a delay in LME inventory destocking. The firm raised its price target for shares to $10 from $7.50.
06:14 EDTAAAlcoa may see turnaround due to investment in aluminum cars, WSJ says
Subscribe for More Information
April 4, 2014
11:31 EDTJCPStocks with call strike movement; JCP TWTR
Subscribe for More Information
09:36 EDTGILDActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL TSLA MU GNK AMZN FB GILD MA NFLX
06:07 EDTJCPStocks with implied volatility below IV index mean; JCP PLUG
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use